Overview

The World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease is a unique multidisciplinary CME conference. It is the premier global conference dedicated to metabolism, obesity, diabetes, the heart and the kidney, incorporating both clinical and basic science.

Why Attend – 2022

The Congress offers attendees a unique experience to interact with the distinguished global faculty, for a collaborative experience that explores the newest understanding of metabolic diseases and the development of future therapeutic modalities.

The congress addresses dyslipidemia, atherosclerosis, hypertension, hypercoagulation, inflammation, and energy metabolism. It provides the newest clinical updates on pharmaceutical interventions such as GLP1ra, SGLT2i’s, PCSK9i’s, MRA and EPA to name a few. The goal is to understand the state-of-the-art pathophysiology, new medical interventions, and to develop appropriate comprehensive clinical management strategies.

To make basic and clinical research topics relevant to clinical medicine, following each session there will be a live Q&A and a discussion on implications to clinical practice.

The program is designed to evaluate the clinical and basic science aspects of diabetes, obesity, HTN, dyslipidemia, CVD, HF, CKD, and related cardiometabolic conditions; focusing on basic science such as insulin resistance, fat cells, inflammation, and clinical practice; understanding the comprehensive management cardiorenalmetabolic conditions.

Faculty experts from around the world will highlight, share, and present the latest research pertaining to the management of the patients with diabetes, cardiorenal, and metabolic diseases.

Sessions will cover the most up-to-date cardiovascular outcome trials and research in—and management recommendations for—obesity, diabetes, insulin resistance, COVID-19, dyslipidemia, ASCVD, heart failure, CKD, cardiorenal metabolism in youth, NAFLD and NASH, the relationship between hormones and atherosclerosis.

The Congress will feature a poster hall and oral abstract presentations, an exhibit hall and industry-supported non-CME programs that will feature important new scientific concepts with some the world’s best-known educators in their fields. 
Why Exhibit – 2022

The Congress is an excellent opportunity for exhibitors to meet with globally-recognized medical leaders, clinicians, and scientists who present and share their knowledge. It is also a good opportunity for exhibitors to expose their products, and services to health care professionals.

Organizer

The Metabolic Endocrine Education Foundation, which administrates WCIRDC and HiD, is a leading national health foundation devoted to improving patient and public health through education.

MEEF, a 501(c)(3) nonprofit organization, sponsors educational activities, such as programs, conferences, and congresses, for professional health providers, patients and the community at large. The goal of the Foundation is to promote understanding around the prevention and diagnosis of medical diseases and to improve the skills of health care providers and enhance the quality of patient's lives.

Source: Event Website